Asahi, Actelion Throw Final Punches In Fasudil IP Row
Asahi Kasei Pharma Corp. urged a California jury on Wednesday to order Actelion Ltd. to pay hundreds of millions of dollars in damages for edging Fasudil out of the market by...To view the full article, register now.
Already a subscriber? Click here to view full article